Möchten Sie immer auf dem neuesten Stand bleiben?

Erstellen Sie noch heute ein Leserkonto, um die Branchen und Unternehmen zu verfolgen, die Sie interessieren, und passen Sie Ihr Nachrichten-Dashboard an.

Beim Leserkonto Anmelden Leserkonto Erstellen

15. Juni 2005 11:46 ET | Quelle: Delcath Systems

Delcath Reports on 2005 Annual Meeting

STAMFORD, Conn., June 15, 2005 (PRIMEZONE) -- Delcath Systems, Inc. (Nasdaq:DCTH) reported shareholders attending the company's 2005 annual meeting voted in favor of the re-election of Samuel...
09. Juni 2005 08:45 ET | Quelle: Delcath Systems

Mid-Year 2005 Letter to Delcath Shareholders

STAMFORD, Conn., June 9, 2005 (PRIMEZONE) -- Delcath Systems, Inc. (Nasdaq:DCTH): Mid-Year Report To Our Stockholders: I am sure most of you are aware of the recent notice we received from the...
24. Mai 2005 08:29 ET | Quelle: Delcath Systems

NCI'S Report on Initial Study of Delcath System in Current Issue of Journal of Clinical Oncology

STAMFORD, Conn., May 24, 2005 (PRIMEZONE) -- Delcath Systems, Inc. (Nasdaq:DCTH) said results of the National Cancer Institute's study of the company's system for delivering high-dose chemotherapy...
11. Mai 2005 11:04 ET | Quelle: Delcath Systems

Delcath Receives Fast-Track Status from U.S. FDA for High Dose Cancer Treatment with Melphalan

STAMFORD, Conn., May 11, 2005 (PRIMEZONE) -- Delcath Systems, Inc. (Nasdaq:DCTH) said its novel system for delivering high dose chemotherapy to specific organs and body regions received fast-track...